Legacy Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Legacy Trust's LLY Position: Q3 2026 in Review
Legacy Trust increased its Eli Lilly (LLY) stake by 60% in Q3 2026, buying an estimated $1.69M and bringing the position to 3,841 shares worth $5.44M. The position accounts for 0.91% of the portfolio, ranked #29.
Legacy Trust first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Legacy Trust held 3,841 shares of Eli Lilly worth $5.44M as of Q3 2026.
- Legacy Trust bought 1,435 Eli Lilly shares in Q3 2026, an estimated $1.69M.
- Eli Lilly made up 0.91% of Legacy Trust's portfolio in Q3 2026, its #29 holding.
- Legacy Trust first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- 3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.